Display options
Share it on

BMC Int Health Hum Rights. 2004 Mar 17;4(1):1. doi: 10.1186/1472-698X-4-1.

Following in the footsteps of smallpox: can we achieve the global eradication of measles?.

BMC international health and human rights

Oliver WC Morgan

Affiliations

  1. Health Protection Agency, North West London Health Protection Unit, London, UK. [email protected]

PMID: 15102333 PMCID: PMC387835 DOI: 10.1186/1472-698X-4-1

Abstract

BACKGROUND: Although an effective measles vaccine has been available for almost 40 years, in 2000 there were about 30 million measles infections worldwide and 777,000 measles-related deaths. The history of smallpox suggests that achieving measles eradication depends on several factors; the biological characteristics of the organism; vaccine technology; surveillance and laboratory identification; effective delivery of vaccination programmes and international commitment to eradication. DISCUSSION: Like smallpox, measles virus has several biological characteristics that favour eradication. Humans are the only reservoir for the virus, which causes a visible illness and infection leading to life-long immunity. As the measles virus has only one genetic serotype which is relatively stable over time, the same basic vaccine can be used world-wide. Vaccination provides protection against measles infection for at least 15 years, although efficacy may be reduced due to host factors such as nutritional status. Measles vaccination may also confer other non-specific health benefits leading to reduced mortality. Accurate laboratory identification of measles cases enables enhanced surveillance to support elimination programmes. The "catch-up, keep-up, follow-up" vaccination programme implemented in the Americas has shown that measles elimination is possible using existing technologies. On 17th October 2003 the "Cape Town Measles Declaration" by the World Health Organisation and the United Nations Childrens Fund called on governments to intensify efforts to reduce measles mortality by supporting universal vaccination coverage and the development of more effective vaccination. SUMMARY: Although more difficult than for smallpox, recent experience in the Americas suggests that measles eradication is technically feasible. Growing international support to deliver these programmes means that measles, like smallpox, may very well become a curiosity of history.

References

  1. Lancet. 2003 Mar 1;361(9359):763-73 - PubMed
  2. Bull World Health Organ. 2003;81(4):244-50 - PubMed
  3. Vaccine. 2003 Mar 28;21(13-14):1423-31 - PubMed
  4. J Infect Dis. 2003 May 15;187 Suppl 1:S15-21 - PubMed
  5. BMJ. 1999 Jul 3;319(7201):4-5 - PubMed
  6. Vaccine. 2003 Jan 30;21(7-8):593-5 - PubMed
  7. Emerg Infect Dis. 1998 Jul-Sep;4(3):412-3 - PubMed
  8. J Infect Dis. 2003 May 15;187 Suppl 1:S264-9 - PubMed
  9. J Infect Dis. 2003 May 15;187 Suppl 1:S51-7 - PubMed
  10. J Infect Dis. 2003 May 15;187 Suppl 1:S1-7 - PubMed
  11. Vaccine. 2003 Jan 17;21(5-6):479-84 - PubMed
  12. Bull World Health Organ. 2001;79(11):1038-46 - PubMed
  13. MMWR Recomm Rep. 1997 Jun 13;46(RR-11):1-20 - PubMed
  14. Bull World Health Organ. 1991;69(4):415-23 - PubMed
  15. Can Commun Dis Rep. 2002 May 15;28(10):81-8 - PubMed
  16. MMWR Morb Mortal Wkly Rep. 2002 Oct 25;51(42):952 - PubMed
  17. J Infect Dis. 2003 May 15;187 Suppl 1:S102-10 - PubMed
  18. BMJ. 1995 Aug 19;311(7003):481-5 - PubMed
  19. J Infect Dis. 2001 Oct 1;184(7):817-26 - PubMed
  20. MMWR Morb Mortal Wkly Rep. 2003 May 23;52(20):471-5 - PubMed
  21. Pediatr Infect Dis J. 1999 Feb;18(2):85-93 - PubMed
  22. Med Microbiol Immunol. 2002 Oct;191(2):75-81 - PubMed
  23. J Infect Dis. 2003 May 15;187 Suppl 1:S283-90 - PubMed
  24. Bull World Health Organ. 1992;70(4):457-60 - PubMed

Publication Types